Serial Number 97898941
Registration 7355281
700

Registration Progress

Application Filed
Apr 20, 2023
Under Examination
Approved for Publication
Jan 23, 2024
Published for Opposition
Jan 23, 2024
Registered
Apr 9, 2024

Trademark Image

Basic Information

Serial Number
97898941
Registration Number
7355281
Filing Date
April 20, 2023
Registration Date
April 9, 2024
Published for Opposition
January 23, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 9, 2024
Registration
Registered
Classes
042

Rights Holder

Hepalink USA Inc.

03
Address
2005 Cabot Boulevard West, Suite 200
Langhorne, PA 190471885

Ownership History

Hepalink USA Inc.

Original Applicant
03
Langhorne, PA

Hepalink USA Inc.

Owner at Publication
03
Langhorne, PA

Hepalink USA Inc.

Original Registrant
03
Langhorne, PA

Legal Representation

Attorney
Gordon M. Wright

USPTO Deadlines

Next Deadline
1618 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-09)
Due Date
April 09, 2030
Grace Period Ends
October 09, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Apr 9, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 9, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 15, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 12, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 12, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 12, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 20, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Nov 20, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
Nov 20, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
Oct 10, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 10, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 10, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 7, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 7, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 28, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 18, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds
First Use Anywhere: Jan 1, 2014
First Use in Commerce: Jan 1, 2014

Additional Information

Design Mark
The mark consists of a stylized design made up of a plurality of solid circles of varying sizes arranged in an hourglass -like shape.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
042